Who was studied, and how
Two numbers in the abstract
Where each one falls
Where it lands on the map
422people in the Effect of Liraglutide on Long-term Weight Maintenance and Additional Weight Loss Induced by a 4 to 12 Week Low Calorie Diet in Obese Subjects; A 56 Week Randomised, Double-blind, Placebo Controlled, Parallel Group, Multicentre Trial With a 12 Week Follow-up Period trial, from 2008
of them with obesity, in this paper
Among Hispanic, the trial randomly assignedassigned by chance
liraglutide 3.0 mg
placebo
May have lowered weight loss−5.10
randomised · one subgroupAmong non-Hispanic, the trial randomly assignedassigned by chance
liraglutide 3.0 mg
placebo
May have lowered weight loss−5.20
randomised · one subgroupthe abstract, start to end
… 7.0% versus 1.5%, treatment difference -5.1% (95% CI, -6.2 to -4.0); non-Hispanics 7.5% versus 2.3%, -5.2% (95% CI, -5.5 to -4.8).
← favours treatmentfavours comparator →
could be chanceMean weight lossliraglutide 3.0 mg vs placebo, in Hispanic
−5.1−6.20 to −4.00
Mean weight lossliraglutide 3.0 mg vs placebo, in non-Hispanic
−5.2−5.50 to −4.80
GLP-1 receptor agonistsBody weight & composition
1 / 4